The Thai Journal of Pharmaceutical Sciences


Background: Alpinia galanga L. (galangal) is a widely known spice in Southeast Asia. A previous study indicated that its active compounds might effectively inhibit (human epidermal growth factor receptor 2 [HER2])-overexpressing breast cancer cell proliferation. Objective: Our study aimed to investigate the antiproliferation activity of galangal extract (GE) on HER2- overexpressing breast cancer cells by analyzing GE cytotoxicity and its mechanism of action. Materials and Methods: We used HCC1954 cell line as a model. We observed the effect of GE (10–200 μg/mL) on cell growth using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The modulation of GE on cell cycle, apoptosis, and the intracellular reactive oxygen species (ROS) level was analyzed using flow cytometry. Moreover, SA-β-galactosidase staining used to observe the cell senescence. Results: Cytotoxic test indicated that GE has modest cytotoxicity toward HCC1954 (IC50 >200 μg/mL) and GE increased cell accumulation at the G2/M phase. Although GE showed no induction on apoptosis, it increased the number of senescent cells. This effect correlated with the increasing intracellular ROS level on treatment with GE. Furthermore, when combined with doxorubicin (Dox), GE increased the Dox’s cytotoxicity.Conclusion: A. galanga antiproliferation activity against HER2-overexpressing breast cancer was associated with its capability to induce cell senescence and intracellular ROS level, causing halted cell cycle progression.



First Page


Last Page


Included in

Pharmacology Commons